1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Diagnostics (CDx) Development Services Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Feasibility Studies
1.2.3 Assay Development
1.2.4 Analytical Validation
1.2.5 Clinical Validation
1.2.6 Others
1.3 Market by Application
1.3.1 Global Companion Diagnostics (CDx) Development Services Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Infectious Diseases
1.3.3 Neurological Disorders
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Companion Diagnostics (CDx) Development Services Market Perspective (2017-2028)
2.2 Companion Diagnostics (CDx) Development Services Growth Trends by Region
2.2.1 Companion Diagnostics (CDx) Development Services Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Companion Diagnostics (CDx) Development Services Historic Market Size by Region (2017-2022)
2.2.3 Companion Diagnostics (CDx) Development Services Forecasted Market Size by Region (2023-2028)
2.3 Companion Diagnostics (CDx) Development Services Market Dynamics
2.3.1 Companion Diagnostics (CDx) Development Services Industry Trends
2.3.2 Companion Diagnostics (CDx) Development Services Market Drivers
2.3.3 Companion Diagnostics (CDx) Development Services Market Challenges
2.3.4 Companion Diagnostics (CDx) Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Diagnostics (CDx) Development Services Players by Revenue
3.1.1 Global Top Companion Diagnostics (CDx) Development Services Players by Revenue (2017-2022)
3.1.2 Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Players (2017-2022)
3.2 Global Companion Diagnostics (CDx) Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Companion Diagnostics (CDx) Development Services Revenue
3.4 Global Companion Diagnostics (CDx) Development Services Market Concentration Ratio
3.4.1 Global Companion Diagnostics (CDx) Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostics (CDx) Development Services Revenue in 2021
3.5 Companion Diagnostics (CDx) Development Services Key Players Head office and Area Served
3.6 Key Players Companion Diagnostics (CDx) Development Services Product Solution and Service
3.7 Date of Enter into Companion Diagnostics (CDx) Development Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Diagnostics (CDx) Development Services Breakdown Data by Type
4.1 Global Companion Diagnostics (CDx) Development Services Historic Market Size by Type (2017-2022)
4.2 Global Companion Diagnostics (CDx) Development Services Forecasted Market Size by Type (2023-2028)
5 Companion Diagnostics (CDx) Development Services Breakdown Data by Application
5.1 Global Companion Diagnostics (CDx) Development Services Historic Market Size by Application (2017-2022)
5.2 Global Companion Diagnostics (CDx) Development Services Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Companion Diagnostics (CDx) Development Services Market Size (2017-2028)
6.2 North America Companion Diagnostics (CDx) Development Services Market Size by Country (2017-2022)
6.3 North America Companion Diagnostics (CDx) Development Services Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Companion Diagnostics (CDx) Development Services Market Size (2017-2028)
7.2 Europe Companion Diagnostics (CDx) Development Services Market Size by Country (2017-2022)
7.3 Europe Companion Diagnostics (CDx) Development Services Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size (2017-2028)
8.2 Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size by Country (2017-2022)
8.3 Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Companion Diagnostics (CDx) Development Services Market Size (2017-2028)
9.2 Latin America Companion Diagnostics (CDx) Development Services Market Size by Country (2017-2022)
9.3 Latin America Companion Diagnostics (CDx) Development Services Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size (2017-2028)
10.2 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Country (2017-2022)
10.3 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Geneuity-Clinical Research Services
11.1.1 Geneuity-Clinical Research Services Company Detail
11.1.2 Geneuity-Clinical Research Services Business Overview
11.1.3 Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Introduction
11.1.4 Geneuity-Clinical Research Services Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.1.5 Geneuity-Clinical Research Services Recent Development
11.2 Interpace Biosciences
11.2.1 Interpace Biosciences Company Detail
11.2.2 Interpace Biosciences Business Overview
11.2.3 Interpace Biosciences Companion Diagnostics (CDx) Development Services Introduction
11.2.4 Interpace Biosciences Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.2.5 Interpace Biosciences Recent Development
11.3 Labcorp
11.3.1 Labcorp Company Detail
11.3.2 Labcorp Business Overview
11.3.3 Labcorp Companion Diagnostics (CDx) Development Services Introduction
11.3.4 Labcorp Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.3.5 Labcorp Recent Development
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Detail
11.4.2 Quest Diagnostics Business Overview
11.4.3 Quest Diagnostics Companion Diagnostics (CDx) Development Services Introduction
11.4.4 Quest Diagnostics Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.4.5 Quest Diagnostics Recent Development
11.5 Q? Solutions
11.5.1 Q? Solutions Company Detail
11.5.2 Q? Solutions Business Overview
11.5.3 Q? Solutions Companion Diagnostics (CDx) Development Services Introduction
11.5.4 Q? Solutions Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.5.5 Q? Solutions Recent Development
11.6 ResearchDx
11.6.1 ResearchDx Company Detail
11.6.2 ResearchDx Business Overview
11.6.3 ResearchDx Companion Diagnostics (CDx) Development Services Introduction
11.6.4 ResearchDx Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.6.5 ResearchDx Recent Development
11.7 Almac Diagnostic Services
11.7.1 Almac Diagnostic Services Company Detail
11.7.2 Almac Diagnostic Services Business Overview
11.7.3 Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Introduction
11.7.4 Almac Diagnostic Services Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.7.5 Almac Diagnostic Services Recent Development
11.8 Biocartis
11.8.1 Biocartis Company Detail
11.8.2 Biocartis Business Overview
11.8.3 Biocartis Companion Diagnostics (CDx) Development Services Introduction
11.8.4 Biocartis Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.8.5 Biocartis Recent Development
11.9 Cerba Research
11.9.1 Cerba Research Company Detail
11.9.2 Cerba Research Business Overview
11.9.3 Cerba Research Companion Diagnostics (CDx) Development Services Introduction
11.9.4 Cerba Research Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.9.5 Cerba Research Recent Development
11.10 Eurofins Scientific
11.10.1 Eurofins Scientific Company Detail
11.10.2 Eurofins Scientific Business Overview
11.10.3 Eurofins Scientific Companion Diagnostics (CDx) Development Services Introduction
11.10.4 Eurofins Scientific Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.10.5 Eurofins Scientific Recent Development
11.11 MLM Medical Labs
11.11.1 MLM Medical Labs Company Detail
11.11.2 MLM Medical Labs Business Overview
11.11.3 MLM Medical Labs Companion Diagnostics (CDx) Development Services Introduction
11.11.4 MLM Medical Labs Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.11.5 MLM Medical Labs Recent Development
11.12 Qiagen
11.12.1 Qiagen Company Detail
11.12.2 Qiagen Business Overview
11.12.3 Qiagen Companion Diagnostics (CDx) Development Services Introduction
11.12.4 Qiagen Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.12.5 Qiagen Recent Development
11.13 BGI Genomics
11.13.1 BGI Genomics Company Detail
11.13.2 BGI Genomics Business Overview
11.13.3 BGI Genomics Companion Diagnostics (CDx) Development Services Introduction
11.13.4 BGI Genomics Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.13.5 BGI Genomics Recent Development
11.14 MEDx Translational Medicine
11.14.1 MEDx Translational Medicine Company Detail
11.14.2 MEDx Translational Medicine Business Overview
11.14.3 MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Introduction
11.14.4 MEDx Translational Medicine Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.14.5 MEDx Translational Medicine Recent Development
11.15 Medical Biological Laboratories (MBL)
11.15.1 Medical Biological Laboratories (MBL) Company Detail
11.15.2 Medical Biological Laboratories (MBL) Business Overview
11.15.3 Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Introduction
11.15.4 Medical Biological Laboratories (MBL) Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.15.5 Medical Biological Laboratories (MBL) Recent Development
11.16 Novogene
11.16.1 Novogene Company Detail
11.16.2 Novogene Business Overview
11.16.3 Novogene Companion Diagnostics (CDx) Development Services Introduction
11.16.4 Novogene Revenue in Companion Diagnostics (CDx) Development Services Business (2017-2022)
11.16.5 Novogene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
